DAY 1 | Auditorium | DAY 1 |
DAY 1 | Auditorium | DAY 1 |
12:00 | Lunch & Networking |
12:00 |
12:05 | 12:05 | |
12:10 | 12:10 | |
12:15 | 12:15 | |
12:20 | 12:20 | |
12:25 | 12:25 | |
12:30 | 12:30 | |
12:35 | 12:35 | |
12:40 | 12:40 | |
12:45 | 12:45 | |
12:50 | 12:50 | |
12:55 | 12:55 | |
1:00 | Site Welcome 13:00 (5 mins) Cliff Dennett, Bruntwood Birmingham Health Innovation Campus. |
1:00: |
1:05: | Welcome and Introductions 13:05 (15 mins) Adrian Freeman, Emerging Innovations Unit, AstraZeneca Saleha Patel, AstraZeneca |
1:05: |
1:10: | 1:10: | |
1:15: | 1:15: | |
1:20: | AstraZeneca Open Innovation: providing the keys to unlock the potential of existing medicines for new indications 13:20 (20 mins) Kelly Gray, Emerging Innovations Unit, AstraZeneca |
1:20: |
1:25: | 1:25: | |
1:30: | 1:30: | |
1:35: | 1:35: | |
1:40: | Repurposing saracatinib as a therapy in acute liver injury 13:40 (20 mins) Patricia Lalor, University of Birmingham |
1:40: |
1:45: | 1:45: | |
1:50: | 1:50: | |
1:55: | 1:55: | |
2:00 | Re-purposing AZD1236 and AZD1390 for use in spinal cord injury 14:00 (20 mins) Zubair Ahmed, Institute of Inflammation and Ageing |
2:00: |
2:05: | 2:05: | |
2:10: | 2:10: | |
2:15: | 2:15: | |
2:20: | Joint Discussion & Q&A Session Chaired by Adrian Freeman 14:20 (40 mins) Kelly Gray, Emerging Innovations Unit, AstraZeneca Zubair Ahmed, Institute of Inflammation and Ageing Patricia Lalor, University of Birmingham |
2:20: |
2:25: | 2:25: | |
2:30: | 2:30: | |
2:35: | 2:35: | |
2:40: | 2:40: | |
2:45: | 2:45: | |
2:50: | 2:50: | |
2:55: | 2:55: | |
3:00 | Coffee & Networking |
3:00: |
3:05: | 3:05: | |
3:10: | 3:10: | |
3:15: | 3:15: | |
3:20: | 3:20: | |
3:25: | 3:25: | |
3:30: | 3:30: | |
3:35: | 3:35: | |
3:40: | 3:40: | |
3:45: | 3:45: | |
3:50: | 3:50: | |
3:55: | 3:55: | |
4:00 | 4:00: |